Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-10-03 Purchase | 2019-10-04 7:58 pm | HERON THERAPEUTICS Inc | HRTX | Quart Barry D CEO | 4,571 | $17.5 | $79,993 | 95,458 (Direct) | View |
| 2018-06-21 Sale | 2018-06-22 9:35 pm | HERON THERAPEUTICS Inc | HRTX | Quart Barry D CEO | 50,000 | $39.05 | $1,952,500 | 321,207 (Direct) | View |
| 2018-03-19 Sale | 2018-03-19 7:22 pm | HERON THERAPEUTICS Inc | HRTX | Quart Barry D CEO | 100,000 | $29.75 | $2,975,000 | 798,269 (Direct) | View |
| 2018-03-14 Sale | 2018-03-16 9:00 pm | HERON THERAPEUTICS Inc | HRTX | Quart Barry D CEO | 100,000 | $24.75 | $2,475,000 | 898,269 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-07-13 Other | 2022-07-15 4:57 pm | N/A N/A | HERON THERAPEUTICS Inc | HRTX | Quart Barry D CEO | 1,504 | $3.842 | 328,604 (Direct) | View |
| 2022-07-13 Tax Withholding | 2022-07-15 4:57 pm | N/A N/A | HERON THERAPEUTICS Inc | HRTX | Quart Barry D CEO | 5,219 | $3.01 | 328,604 (Direct) | View |
| 2022-07-13 Exercise | 2022-07-15 4:57 pm | N/A N/A | HERON THERAPEUTICS Inc | HRTX | Quart Barry D CEO | 19,768 | $0 | 328,604 (Direct) | View |
| 2022-06-29 Option Award | 2022-06-30 4:22 pm | N/A 2032-06-28 | Kiniksa Pharmaceuticals Ltd. | KNSA | Quart Barry D Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2022-04-13 Tax Withholding | 2022-04-15 5:05 pm | N/A N/A | HERON THERAPEUTICS Inc | HRTX | Quart Barry D CEO | 5,219 | $6.07 | 330,815 (Direct) | View |
| 2022-04-13 Exercise | 2022-04-15 5:05 pm | N/A N/A | HERON THERAPEUTICS Inc | HRTX | Quart Barry D CEO | 19,768 | $0 | 330,815 (Direct) | View |
| 2022-01-13 Tax Withholding | 2022-01-14 5:08 pm | N/A N/A | HERON THERAPEUTICS Inc | HRTX | Quart Barry D CEO | 5,219 | $8.3 | 336,034 (Direct) | View |
| 2022-01-13 Exercise | 2022-01-14 5:08 pm | N/A N/A | HERON THERAPEUTICS Inc | HRTX | Quart Barry D CEO | 19,768 | $0 | 336,034 (Direct) | View |
| 2021-10-13 Tax Withholding | 2021-10-15 4:25 pm | N/A N/A | HERON THERAPEUTICS Inc | HRTX | Quart Barry D CEO | 963 | $10.55 | 732,087 (Direct) | View |
| 2021-10-13 Option Award | 2021-10-15 4:25 pm | N/A 2031-10-13 | HERON THERAPEUTICS Inc | HRTX | Quart Barry D CEO | 586,251 | $0 | 732,087 (Direct) | View |
| 2021-10-13 Exercise | 2021-10-15 4:25 pm | N/A N/A | HERON THERAPEUTICS Inc | HRTX | Quart Barry D CEO | 3,646 | $0 | 732,087 (Direct) | View |
| 2021-07-13 Tax Withholding | 2021-07-15 4:50 pm | N/A N/A | HERON THERAPEUTICS Inc | HRTX | Quart Barry D CEO | 963 | $13.48 | 148,328 (Direct) | View |
| 2021-07-13 Other | 2021-07-15 4:50 pm | N/A N/A | HERON THERAPEUTICS Inc | HRTX | Quart Barry D CEO | 1,529 | $13.9 | 148,328 (Direct) | View |
| 2021-07-13 Exercise | 2021-07-15 4:50 pm | N/A N/A | HERON THERAPEUTICS Inc | HRTX | Quart Barry D CEO | 3,645 | $0 | 148,328 (Direct) | View |
| 2021-06-29 Option Award | 2021-06-30 4:20 pm | N/A 2031-06-28 | Kiniksa Pharmaceuticals Ltd. | KNSA | Quart Barry D Director | 33,237 | $0 | 33,237 (Direct) | View |
| 2021-01-13 Tax Withholding | 2021-01-15 4:29 pm | N/A N/A | HERON THERAPEUTICS Inc | HRTX | Quart Barry D CEO | 963 | $18.16 | 146,596 (Direct) | View |
| 2021-01-13 Exercise | 2021-01-15 4:29 pm | N/A N/A | HERON THERAPEUTICS Inc | HRTX | Quart Barry D CEO | 3,646 | $0 | 146,596 (Direct) | View |
| 2020-10-13 Option Award | 2020-10-15 4:23 pm | N/A 2030-10-13 | HERON THERAPEUTICS Inc | HRTX | Quart Barry D CEO | 408,333 | $0 | 498,717 (Direct) | View |
| 2020-10-13 Other | 2020-10-15 4:23 pm | N/A N/A | HERON THERAPEUTICS Inc | HRTX | Quart Barry D CEO | 1,158 | $12.12 | 498,717 (Direct) | View |
| 2020-06-30 Option Award | 2020-07-02 4:12 pm | N/A 2030-06-29 | Kiniksa Pharmaceuticals Ltd. | KNSA | Quart Barry D Director | 18,760 | $0 | 18,760 (Direct) | View |
| 2019-12-31 Ownership | 2020-02-14 4:56 pm | N/A N/A | HERON THERAPEUTICS Inc | HRTX | Quart Barry D CEO | 6,584 | $0 | 88,068 (Direct) | View |
| 2019-12-19 Option Award | 2019-12-23 4:29 pm | N/A 2029-12-19 | HERON THERAPEUTICS Inc | HRTX | Quart Barry D CEO | 325,000 | $0 | 325,000 (Direct) | View |
| 2019-10-03 Other | 2019-10-04 7:58 pm | N/A N/A | HERON THERAPEUTICS Inc | HRTX | Quart Barry D CEO | 806 | $18.43 | 95,458 (Direct) | View |
| 2019-05-29 Option Award | 2019-05-30 6:33 pm | N/A 2029-05-28 | Kiniksa Pharmaceuticals Ltd. | KNSA | Quart Barry D Director | 18,760 | $0 | 18,760 (Direct) | View |
| 2018-12-15 Option Award | 2018-12-18 8:09 pm | N/A 2028-12-15 | HERON THERAPEUTICS Inc | HRTX | Quart Barry D CEO | 300,000 | $0 | 300,000 (Direct) | View |
| 2018-09-14 Exercise | 2018-09-14 11:41 am | N/A N/A | HERON THERAPEUTICS Inc | HRTX | Quart Barry D CEO | 19,675 | $7.2 | 799,876 (Direct) | View |
| 2018-09-14 Exercise | 2018-09-14 11:41 am | N/A 2023-05-01 | HERON THERAPEUTICS Inc | HRTX | Quart Barry D CEO | 19,675 | $0 | 799,876 (Direct) | View |
| 2018-06-21 Other | 2018-06-22 9:35 pm | N/A N/A | HERON THERAPEUTICS Inc | HRTX | Quart Barry D CEO | 1,607 | $13.22 | 321,207 (Direct) | View |
| 2018-06-21 Exercise | 2018-06-22 9:35 pm | N/A 2024-12-12 | HERON THERAPEUTICS Inc | HRTX | Quart Barry D CEO | 50,000 | $0 | 321,207 (Direct) | View |
| 2018-06-21 Exercise | 2018-06-22 9:35 pm | N/A N/A | HERON THERAPEUTICS Inc | HRTX | Quart Barry D CEO | 50,000 | $9.05 | 321,207 (Direct) | View |
| 2018-05-23 Ownership | 2018-05-23 8:11 pm | N/A 2025-12-15 | Kiniksa Pharmaceuticals Ltd. | KNSA | Quart Barry D Director | 0 | $0 | 69,536 (Direct) | View |
| 2018-03-19 Exercise | 2018-03-19 7:22 pm | N/A N/A | HERON THERAPEUTICS Inc | HRTX | Quart Barry D CEO | 100,000 | $7.2 | 798,269 (Direct) | View |
| 2018-03-19 Exercise | 2018-03-19 7:22 pm | N/A 2023-05-01 | HERON THERAPEUTICS Inc | HRTX | Quart Barry D CEO | 100,000 | $0 | 798,269 (Direct) | View |
| 2018-03-14 Exercise | 2018-03-16 9:00 pm | N/A N/A | HERON THERAPEUTICS Inc | HRTX | Quart Barry D CEO | 100,000 | $7.2 | 898,269 (Direct) | View |
| 2018-03-14 Exercise | 2018-03-16 9:00 pm | N/A 2023-05-01 | HERON THERAPEUTICS Inc | HRTX | Quart Barry D CEO | 100,000 | $0 | 898,269 (Direct) | View |
| 2017-12-18 Option Award | 2017-12-20 4:15 pm | N/A 2027-12-18 | HERON THERAPEUTICS Inc | HRTX | Quart Barry D CEO | 310,000 | $0 | 379,677 (Direct) | View |
| 2017-12-18 Other | 2017-12-20 4:15 pm | N/A N/A | HERON THERAPEUTICS Inc | HRTX | Quart Barry D CEO | 1,684 | $12.62 | 379,677 (Direct) | View |